Condition
Neuroendocrine Carcinomas clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Neuroendocrine Carcinomas clinical trials that are recruiting, at sites in 5 countries (most in United States (3), Argentina (1), Brazil (1)). By phase: Phase 1 (1), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Neuroendocrine Carcinomas clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| CTX-471 for NCAM-positive metastatic neuroendocrine tumors | Phase 2 | St Louis, Missouri and 1 other locations | Recruiting | Jul 6, 2026 |
| Neuroendocrine Carcinomas: Patient Paths and Outcomes in Latin America | — | Buenos Aires, Buenos Aires and 18 other locations | Recruiting | Sep 25, 2025 |
| IDE849 for DLL3-expressing tumors including small-cell lung cancer | Phase 1/2 | Denver, Colorado and 12 other locations | Recruiting | Sep 16, 2025 |
| Testing ADCT-701 for treating neuroendocrine tumors and carcinomas | Phase 1 | Bethesda, Maryland | Recruiting | Sep 18, 2023 |
All recruiting trials (4)
-
CTX-471 for NCAM-positive metastatic neuroendocrine tumors
A phase 2 trial is testing CTX-471 in adults with NCAM (CD56) positive metastatic neuroendocrine tumors that have progressed after standard therapy.
-
Neuroendocrine Carcinomas: Patient Paths and Outcomes in Latin America
This is an observational study that will look at medical records to see how patients with neuroendocrine carcinomas in Latin America are diagnosed, treated, and how they fare.
-
IDE849 for DLL3-expressing tumors including small-cell lung cancer
This trial tests IDE849, alone and with durvalumab or IDE161, to see if it is safe and can shrink DLL3-positive tumors in people with small-cell lung cancer or other DLL3-expressing cancers.
-
Testing ADCT-701 for treating neuroendocrine tumors and carcinomas
This study is testing a new drug called ADCT-701 to see if it can safely help adults with neuroendocrine tumors and certain types of cancer.
Related topics
Quick answers
How many Neuroendocrine Carcinomas clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), Argentina (1 trial), Brazil (1 trial), Mexico (1 trial), Peru (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.